Cost-effectiveness of the hospital nutrition screening tool CIPA
Copyright: © 2019 Termedia & Banach..
INTRODUCTION: Hospital malnutrition is very common and worsens the clinical course of patients while increasing costs. Lacking clinical-economic studies on the implementation of nutrition screening encouraged the evaluation of the CIPA (Control of Food Intake, Protein, Anthropometry) tool.
MATERIAL AND METHODS: An open, non-randomized, controlled clinical trial was conducted on patients admitted to internal medicine and general and digestive surgery wards, who were either assigned to a control (standard hospital clinical care) or to an intervention, CIPA-performing ward (412 and 411, respectively; n = 823). Length of stay, mortality, readmission, in-hospital complications, and quality of life were evaluated. Cost-effectiveness was analysed in terms of cost per quality-adjusted life years (QALYs).
RESULTS: The mean length of stay was higher in the CIPA group, though not significantly (+ 0.95 days; p = 0.230). On the surgical ward, more patients from the control group moved to critical care units (p = 0.014); the other clinical variables did not vary. Quality of life at discharge was similar (p = 0.53), although slightly higher in the CIPA group at 3 months (p = 0.089). Patients under CIPA screening had a higher mean cost of € 691.6 and a mean QALY gain over a 3-month period of 0.0042. While the cost per QALY for the internal medicine patients was € 642 282, the results for surgical patients suggest that the screening tool is both less costly and more effective.
CONCLUSIONS: The CIPA nutrition screening tool is likely to be cost-effective in surgical but not in internal medicine patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Archives of medical science : AMS - 16(2020), 2 vom: 07., Seite 273-281 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Suárez-Llanos, José Pablo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cost-benefit analysis |
|---|
| Anmerkungen: |
Date Revised 13.11.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5114/aoms.2018.81128 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307765911 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307765911 | ||
| 003 | DE-627 | ||
| 005 | 20231226201239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5114/aoms.2018.81128 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1025.xml |
| 035 | |a (DE-627)NLM307765911 | ||
| 035 | |a (NLM)32190136 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Suárez-Llanos, José Pablo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cost-effectiveness of the hospital nutrition screening tool CIPA |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2019 Termedia & Banach. | ||
| 520 | |a INTRODUCTION: Hospital malnutrition is very common and worsens the clinical course of patients while increasing costs. Lacking clinical-economic studies on the implementation of nutrition screening encouraged the evaluation of the CIPA (Control of Food Intake, Protein, Anthropometry) tool | ||
| 520 | |a MATERIAL AND METHODS: An open, non-randomized, controlled clinical trial was conducted on patients admitted to internal medicine and general and digestive surgery wards, who were either assigned to a control (standard hospital clinical care) or to an intervention, CIPA-performing ward (412 and 411, respectively; n = 823). Length of stay, mortality, readmission, in-hospital complications, and quality of life were evaluated. Cost-effectiveness was analysed in terms of cost per quality-adjusted life years (QALYs) | ||
| 520 | |a RESULTS: The mean length of stay was higher in the CIPA group, though not significantly (+ 0.95 days; p = 0.230). On the surgical ward, more patients from the control group moved to critical care units (p = 0.014); the other clinical variables did not vary. Quality of life at discharge was similar (p = 0.53), although slightly higher in the CIPA group at 3 months (p = 0.089). Patients under CIPA screening had a higher mean cost of € 691.6 and a mean QALY gain over a 3-month period of 0.0042. While the cost per QALY for the internal medicine patients was € 642 282, the results for surgical patients suggest that the screening tool is both less costly and more effective | ||
| 520 | |a CONCLUSIONS: The CIPA nutrition screening tool is likely to be cost-effective in surgical but not in internal medicine patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cost-benefit analysis | |
| 650 | 4 | |a inpatients | |
| 650 | 4 | |a malnutrition | |
| 650 | 4 | |a nutrition assessment | |
| 650 | 4 | |a quality of life | |
| 700 | 1 | |a Vallejo-Torres, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a García-Bello, Miguel Ángel |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-Carballo, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Calderón-Ledezma, Eduardo Mauricio |e verfasserin |4 aut | |
| 700 | 1 | |a Rosat-Rodrigo, Adriá |e verfasserin |4 aut | |
| 700 | 1 | |a Delgado-Brito, Irina |e verfasserin |4 aut | |
| 700 | 1 | |a Pereyra-García-Castro, Francisca |e verfasserin |4 aut | |
| 700 | 1 | |a Benitez-Brito, Nestor |e verfasserin |4 aut | |
| 700 | 1 | |a Felipe-Pérez, Nieves |e verfasserin |4 aut | |
| 700 | 1 | |a Ramallo-Fariña, Yolanda |e verfasserin |4 aut | |
| 700 | 1 | |a Romero-Pérez, Juan Carlos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of medical science : AMS |d 2010 |g 16(2020), 2 vom: 07., Seite 273-281 |w (DE-627)NLM21577972X |x 1734-1922 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2020 |g number:2 |g day:07 |g pages:273-281 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5114/aoms.2018.81128 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2020 |e 2 |b 07 |h 273-281 | ||